Opendata, web and dolomites
H2020 projects about "vaccines"
The page lists 186 projects related to the topic "vaccines".
| # | |||
|---|---|---|---|
| 1 | SAPHIR | Strengthening Animal Production and Health through the Immune Response | 2015 |
| 2 | APERIM | APERIM: Advanced bioinformatics platform for PERsonalised cancer IMmunotherapy | 2015 |
| 3 | ParaFishControl | Advanced Tools and Research Strategies for Parasite Control in European farmed fish | 2015 |
| 4 | I-MOVE-plus | I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly | 2015 |
| 5 | MycoSynVac | Engineering of Mycoplasma pneumoniae as a broad-spectrum animal vaccine | 2015 |
| 6 | Paragone | PARAGONE: vaccines for animal parasites | 2015 |
| 7 | DiViNe | Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes | 2015 |
| 8 | EMI-TB | Eliciting Mucosal Immunity to Tuberculosis | 2015 |
| 9 | Vaccinesurvey | Monitor population immunity against vaccine preventable diseases | 2015 |
| 10 | MACIVIVA | MAnufacturing process for Cold-chain Independent VIrosome-based VAccines | 2015 |
| 11 | BIZEB | Bio-Imaging of Zoonotic and Emerging Bunyaviruses | 2015 |
| 12 | AUTOOLIGO | Automated synthesis of S. pneumoniae 7F capsular polysaccharide repeating unit as candidate for conjugate vaccines | 2015 |
| 13 | iNEXT | Infrastructure for NMR, EM and X-rays for translational research | 2015 |
| 14 | PneumoCompetence | Unravelling the mechanisms of competence induction by antibiotic stress in Streptococcus pneumoniae | 2015 |
| 15 | ARENAVIRUS | Molecular mechanisms of arenavirus cell entry and antibody-mediated neutralization | 2015 |
| 16 | Micropod | MICROPOrous Devices for next-generation therapeutic delivery | 2015 |
| 17 | HistoricEpi | Quantiative Study of Major Historic Epidemics and Transitions to longer, healthier lives | 2015 |
| 18 | SchmaVirusVacDiag | Novel vaccine and diagnostic strategies against Schmallenberg virus | 2015 |
| 19 | LABVaccFish | USE OF LACTIC ACID BACTERIA AS DELIVERY VEHICLE FOR ORAL VACCINATION OF FISH | 2016 |
| 20 | REACTION | Evaluation of the efficacy and of the antiviral activity of T-705 (favipiravir) duringEbola virus infection in non-human primates humans | 2014 |
| 21 | EVIDENT | Ebola Virus Disease - correlates of protection, determinants of outcome, and clinical management | 2014 |
| 22 | FACTs | Fast Acting Virus Control Strategies for Production Animal Diseases | 2015 |
| 23 | SVNanoVax | Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy | 2015 |
| 24 | NEWCARBOVAX | New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism | 2017 |
| 25 | DermalTherapy | Membrane fusion mediated dermal allergy immunotherapy | 2015 |
| 26 | RIPEB | Rapid heat inactivation of pathogens to enable biomarker research | 2015 |
| 27 | TEC_Pro | Molecular control of self-renewal and lineage specification in thymic epithelial cell progenitors in vivo. | 2015 |
| 28 | MucoVac | Unravelling the mode of action of mucosal adjuvants | 2016 |
| 29 | BCELLMECHANICS | Regulation of antibody responses by B cell mechanical activity | 2015 |
| 30 | EVOLPROOF | Are HPV vaccines ‘evolution-proof’? Multilevel evolutionary ecology of human oncoviruses | 2015 |
| 31 | GLYCOVAX | A training network for the rational design of the next generation of well-defined glycoconjugate vaccines | 2015 |
| 32 | StableVax | Commercialisation of a world changing invention for the stabilisation and delivery of vaccines | 2015 |
| 33 | CerviVax | New Generation Therapeutic vaccine for the Treatment of HPV infections and Cervical Dysplasia | 2015 |
| 34 | NEURIMMUNE | Neural regulation of immunity | 2015 |
| 35 | BROADimmune | Structural, genetic and functional analyses of broadly neutralizing antibodies against human pathogens | 2015 |
| 36 | SWEETOOLS | Smart Biologics: Developing New Tools in Glycobiology | 2016 |
| 37 | CODOVIREVOL | Evolution of viral codon usage preferences:manipulation of translation accuracy and evasion of immune response | 2016 |
| 38 | EHVA | European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates | 2016 |
| 39 | RENOIR | Reverse EngiNeering of sOcial Information pRocessing | 2016 |
| 40 | SAL ETHVI | Innovative, easily applicable vaccine for poultry industry against five Salmonella serovars: Enteritidis, Typhimurium, Hadar, Virchow and Infantis – SAL ETHVI | 2016 |
| 41 | DISSection | Doctoral Industrial School on Human Skin models for Staphylococcal infections | 2016 |
| 42 | VADEMA | Doctoral Industrial School for Vaccine Design through Structural Mass Spectrometry | 2016 |
| 43 | TARG-SUP | Targeting TGF-β activation, likely the core mechanism of immunosuppression by human regulatory T cells. | 2016 |
| 44 | PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | 2016 |
| 45 | DynOMIS | Dynamic Origins of MHC class I Selector function | 2016 |
| 46 | GLUTORHIV | Glucose metabolism and mTOR pathway role in CD8+ T cell control of HIV-1 | 2016 |
| 47 | NanoCap | Sustainable Polypeptide Nanoparticle Platform for Drug Delivery | 2016 |
| 48 | PRONKJEWAIL | Protecting patients with enhanced susceptibility to infections | 2016 |
| 49 | EDGE | Training network providing cutting-EDGE knowlEDGE on Herpes Virology and Immunology | 2016 |
| 50 | SugarBlock | Unraveling the protein glycosylation of Plasmodium falciparum is crucial for development of novel therapeutics against malaria | 2016 |
| 51 | PIGYVAX | Making a yeast-based candidate vaccine against Porcine Epidemic Diarrhea Virus (PEDV) | 2016 |
| 52 | Antibodyomics | Vaccine profiling and immunodiagnostic discovery by high-throughput antibody repertoire analysis | 2016 |
| 53 | PeptiCrad | Personalized oncolytic vaccines for cancer immunotherapy | 2016 |
| 54 | DEBUNKER | The Problem of European Misperceptions in Politics, Health, and Science:Causes, Consequences, and the Search for Solutions | 2016 |
| 55 | SAP-Nano | A disruptive technology for vaccines manufacturing based on Self-Assembled Polymeric Nanoparticulate systems | 2016 |
| 56 | Born-Immune | Shaping of the Human Immune System by Primal Environmental Exposures In the Newborn Child | 2016 |
| 57 | CHEMCHECK | CHECKPOINTS IN CHECK: Novel Chemical Toolbox for Local Cancer Immunotherapy | 2016 |
| 58 | B-response | Memory and innate-like B-cell subsets: deciphering a multi-layered B-cell response in mice and humans | 2016 |
| 59 | STRAVIR | Role of the stroma-derived ‘alarmin’ IL-33 in anti-viral immunity | 2016 |
| 60 | PHA-ST-TRAIN-VAC | Leveraging Pharmaceutical Sciences and Structural Biology Training to develop 21st Century Vaccines | 2016 |
| 61 | SIRCAH | Secretariat for the International Research Consortium on Animal Health | 2016 |
| 62 | BITCAT | Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy | 2017 |
| 63 | ImmProDynamics | Dissecting the interplay between the dynamics of immune responses and pathogen proliferation in vivo | 2017 |
| 64 | T-TAG | Innovative tag system providing affordable time-temperature quality control of individual temperature sensitive products | 2016 |
| 65 | VACCELERAID | A novel vaccine technology leading to accelerated availability of vaccines and improved delivery | 2016 |
| 66 | ExtremoChem | Chemically synthesised novel compounds for the stabilisation of biologics | 2016 |
| 67 | ZIKAVAX | Fast track development of a Zika vaccine based on measles vector | 2016 |
| 68 | MultiViVax | Development of Effective Vaccines against Multiple Lifecycle Stages of Plasmodium vivax malaria | 2017 |
| 69 | RABYD-VAX | Development of a Next-Generation, Dual-Target Rabies/Flavivirus Infectious DNA (iDNA) Vaccine | 2017 |
| 70 | OptiMalVax | Optimizing a deployable high efficacy malaria vaccine | 2017 |
| 71 | HIVACAR | Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection | 2017 |
| 72 | ADJUV-ANT VACCINES | Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines | 2017 |
| 73 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 74 | NMR4Nanos | Development and application of NMR-based tools to inorganic nanocarriers for effective vaccine delivery | 2017 |
| 75 | STRUGGLE | Statistical physics of immune-viral co-evolution | 2017 |
| 76 | VIVAVE | Viral Vaccine Vectors in Personalized Medicine | 2017 |
| 77 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
| 78 | ChiPyrNMR | Better tools for combating insect borne diseases by understanding influences on the fate of common pesticides in paint formulations | 2017 |
| 79 | TracVac | Developing a Chlamydia Trachomatis vaccine | 2017 |
| 80 | PE-FECATS | Pasteur's Empire - French Expertise, Colonialism, and Transnational Science | 2017 |
| 81 | IRWIC | Influence of Insecticide Resistance, Wolbachia and their Interaction on Chikungunya transmission | 2017 |
| 82 | FusionPAMPs | New generation of chimeric TLR2-NOD agonist compounds for vaccine adjuvants | 2017 |
| 83 | SupaSteD | Suppresion of adaptive immunity by the Salmonella effector SteD | 2017 |
| 84 | StressEBOV | Ebola virus manipulation of the cellular stress responses | 2017 |
| 85 | VSV-EBOVAC | Vaccine safety and immunogenicity signatures of human responses to VSV-ZEBOV – Sofia ref.: 115842 | 2015 |
| 86 | EBODAC | Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847 | 2014 |
| 87 | PERISCOPE | PERtussIS COrrelates of Protection Europe - Sofia ref.: 115910 | 2016 |
| 88 | VAC2VAC | Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 | 2016 |
| 89 | RESCEU | REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 | 2017 |
| 90 | PolyVac | Polysaccharide-based membrane for sublingual vaccination | 2017 |
| 91 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
| 92 | I-CONSENT | Improving the guidelines for Informed Consent, including vulnerable populations, under a gender perspective | 2017 |
| 93 | BoVLP-BVD | Development of Tagged (DIVA), Virus-Like-Particle polyantigenic Vaccine against Bovine Viral Diarrhea virus (BVDc) | 2017 |
| 94 | PALE-Blu | Understanding pathogen, livestock, environment interactions involving bluetongue virus | 2017 |
| 95 | SynVaccine | Rational Design and Construction of Viral Based Products | 2017 |
| 96 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2017 |
| 97 | PEVIA | PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 | 2017 |
| 98 | TransfoPneumo | Structure and Function of the Bacterial Transformasome | 2017 |
| 99 | Super-Vaccine | Exploring the potential applications of live viral vaccine encoded small-hairpin-RNAs in improving both vaccine safety and efficacy through RNA-interference and stimulation of the innate immune system | 2018 |
| 100 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 101 | CELLUP | Innovative in-line Raman analytical sensor for new upstream cell culture monitoring and quality control | 2017 |
| 102 | TRANSVAC2 | European Vaccine Research and Development Infrastructure | 2017 |
| 103 | DRIVE | Development of Robust and Innovative Vaccine Effectiveness | 2017 |
| 104 | SWINOSTICS | Swine diseases field diagnostics toolbox | 2017 |
| 105 | BIOSIM | Accelerating the commercialisation of a disruptive analytical technology which enables the biopharmaceutical industry to manufacture drugs faster, cheaper and with greater regulatory confidence | 2017 |
| 106 | IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer | 2017 |
| 107 | OMVCRC | Engineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapy | 2018 |
| 108 | ImmuneHunter | Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously | 2017 |
| 109 | DynaMO_TB | Spatiotemporal regulation of localization and replication of M. tuberculosis in humanmacrophages | 2018 |
| 110 | HIV B Cell Function | Understanding HIV-specific B cell function and viral immunogenicity | 2018 |
| 111 | CC-LEGO | CC-LEGO: robust protein blocks to build cages and layers | 2018 |
| 112 | MISTRO | Identification of the cellular sites of cytomegalovirus latency that contribute to the induction of inflationary CD8 T cell memory against the virus. | 2018 |
| 113 | COMFECTION | Communication for Food Protection | 2019 |
| 114 | SEXinMALARIA | Sex in malaria parasites – from basic biology to targets for transmission blocking interventions. | 2018 |
| 115 | TC-Evo | Molecular and functional evolution of human CD8+ T cell repertoires | 2018 |
| 116 | TREGinAD | Role of Aβ Specific Regulatory T cells in harnessing cerebral Aβ clearance in Alzheimer’s Disease | 2018 |
| 117 | RNAmpMax | Maximization of amplification of next-generation RNA replicon vaccines through synergistic molecular and formulation design | 2019 |
| 118 | EvISC | Infection of the human intestine by enteroviruses: A CRISPR-based screening approach | 2019 |
| 119 | FluPRINT | Tracing the inFLUenza vaccine imPRINT on immune system to identify cellular signature of protection | 2018 |
| 120 | ENGEMED | Simulating the dynamics of viral evolution: A computer-aided study toward engineering effective vaccines | 2018 |
| 121 | VACMA | Vaccine Media Analytics | 2018 |
| 122 | GammaDelta | DECIPHERING THE MEMORY OF gd T CELLS: DOES IT HAVE A ROLE IN CROSS-PROTECTION OF BACILLE CALMETTE-GUERIN VACCINATION? | 2018 |
| 123 | DEFEND | Addressing the dual emerging threats of African Swine Fever and Lumpy Skin Disease in Europe (DEFEND) | 2018 |
| 124 | DCPOIESIS | Steady-state and demand-driven dendritic cell generation | 2018 |
| 125 | IMMUNEDIVERSITY | Defining of human adaptive immune gene diversity and its impact on disease | 2018 |
| 126 | evFOUNDRY | The Extracellular Vesicle Foundry | 2018 |
| 127 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 128 | BIOCOPY | BIOCOPY: the new biomolecule copying and screening solution for diagnostics and therapeutics | 2018 |
| 129 | EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure | 2018 |
| 130 | RAPID | RNA particles for Preparedness against Infectious Diseases | 2018 |
| 131 | FORMBECC | LaminarPace System: a breakthrough technology for dry-formulation of sensitive pharmaceuticals at room temperature enhancing their stability beyond the cold chain | 2018 |
| 132 | VacPath | Novel vaccine vectors to resist pathogen challenge | 2019 |
| 133 | vAMRes | Vaccines as a remedy for antimicrobial resistant bacterial infections | 2018 |
| 134 | HSciRO | Handle with Science | 2018 |
| 135 | ImmunoCode | Digital Single Cell Immunology: Decoding Cellular Interactions for Improved Immunotherapy | 2018 |
| 136 | BGV1 | New vaccine for a paradigm shift in Brucellosis | 2018 |
| 137 | PanCaVax | Personalised Pancreatic Cancer Vaccination Therapy derived from Autologous Tumor Cells and Neoantigens | 2018 |
| 138 | QUEST | QUality and Effectiveness in Science and Technology communication | 2019 |
| 139 | Sugar-Enable | Influenza Virus - Sugar Interactions, From Glycan Arrays To Better Vaccines | 2018 |
| 140 | SyrinJector | SyrinJector, the first smart device for livestock mass vaccination. | 2018 |
| 141 | ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response. | 2019 |
| 142 | CONCISE | Communication role on perception and beliefs of EU Citizens about Science | 2018 |
| 143 | FuncMAB | High-throughput single-cell phenotypic analysis of functional antibody repertoires | 2019 |
| 144 | VITAL | Vaccines and Infectious Diseases in the Ageing PopuLation | 2019 |
| 145 | skILL | Intracellular signalling by modified lipopolysaccharide | 2019 |
| 146 | SUPRAVACC | Supramolecular engineering of glycan-decorated peptides as synthetic vaccines | 2019 |
| 147 | CAOS | Containment, Avalanches and Optimisation in Spreading-processes | 2019 |
| 148 | MGLycan | Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer | 2019 |
| 149 | FUSEDESIGN | Model-guided design of a stabilized pre-fusion class III viral fusogen, rabies virus glycoprotein | 2019 |
| 150 | LUNG-BIM | Induction of B cell immunity in the lung mucosa | 2019 |
| 151 | ARGONAUT | ARGONAUT: from the synthesis of gAnglioside tumouR antiGens to a platfOrm for caNcer Active immUnoTherapy | 2019 |
| 152 | SHIGETECVAX | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | 2019 |
| 153 | BoVLP-BVD | Tagged (DIVA) polyantigenic vaccine against Bovine Viral Diarrhea virus (BVDv) based on virus-Like-Particles | 2019 |
| 154 | B-different | The RNA-Binding Protein ZFP36L1 regulates the terminal differentiation of B lymphocytes | 2020 |
| 155 | VASA | Vaccine Against Schistosomiasis for Africa. A Phase I clinical study of the SchistoShield® anti-schistosomiasis vaccine in adults in endemic areas of sub-Saharan Africa | 2019 |
| 156 | PnuBioVax | PnuBioVax™: next-generation vaccine for a personalised and effective immune response against Streptococcus pneumoniae. | 2019 |
| 157 | 3DBrainStrom | Brain metastases: Deciphering tumor-stroma interactions in three dimensions for the rational design of nanomedicines | 2019 |
| 158 | OvaVAx | 100% Bacteria free eggs for use in production of human and animal vaccines | 2019 |
| 159 | Genetic Vaccine | Study the therapeutic and preventive potential of targeting oncogenic mutations with CRISPR-Cas9 technology | 2019 |
| 160 | MEDIVAC | Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems | 2019 |
| 161 | STREPUNLOCKED | Unlocking the antibiotic production potential in soil bacteria Streptomyces coelicolor | 2019 |
| 162 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 163 | NaviFlu | Navigating the evolutionary routes of influenza viruses | 2019 |
| 164 | COMBIVET | Setting up the ERA Chair of Comparative Medicine in the Institute of Veterinary Medicine and Animal Sciences of the Estonian University of Life Sciences | 2019 |
| 165 | FRAME | FRAME - tumor genome-based personalized anti-cancer vaccines off-the-shelf | 2019 |
| 166 | StreptoMANIAC | Cost and benefit of beta-lactam resistance in Streptococcus pneumoniae: interplay between the resistance determinants and the cell elongation/division components | 2019 |
| 167 | BactiVax | anti-Bacterial Innovative Vaccine Training Network. | 2019 |
| 168 | ECRC | Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola | 2019 |
| 169 | VACDIVA | A safe DIVA vaccine for African Swine Fever control and eradication | 2019 |
| 170 | ICRAD | INTERNATIONAL COORDINATION OF RESEARCH ON INFECTIOUS ANIMAL DISEASES | 2019 |
| 171 | TRAIN-OLD | Trained immunity: improving the next generation of vaccines for the older generation | 2019 |
| 172 | VIVA | Vaccine development against variable pathogens | 2020 |
| 173 | FIDA | Scale-up of our disruptive antibody analytical platform based in flow-induced dispersion analysis (FIDA) to increase efficiency in the research of new antibodies and vaccines | 2019 |
| 174 | PAVax | A training network for the design of new synthetic carbohydrate-based vaccines to combat antibiotic resistant Pseudomonas aeruginosa | 2020 |
| 175 | ISOLDA | Improved Vaccination Strategies for Older Adults | 2020 |
| 176 | INDIGO | Effective and Affordable Flu Vaccines for the World | 2020 |
| 177 | iNEXT-Discovery | Infrastructure for transnational access and discovery in structural biology | 2020 |
| 178 | PEPTOX | An innovative peptide system for novel drugs targeting microbial Repeats-In-Toxin adhesins | 2020 |
| 179 | INCENTIVE | Indo-European Consortium for Next Generation Influenza Vaccine Innovation | 2020 |
| 180 | KineTic | New Reagents for Quantifying the Routing and Kinetics of T-cell Activation | 2020 |
| 181 | BGV1 | New vaccine for a paradigm shift in Brucellosis, one of the world’s most widespread zoonotic diseases affecting humans | 2020 |
| 182 | QS21-Mech | Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech) | 2020 |
| 183 | Valvax | Evaluating the Long-Run Socioeconomic Effects of Childhood Vaccination | 2020 |
| 184 | VacTrack | Dissecting the protection mechanism of new generation vaccines by synchronizing systems biology with in vivo imaging | 2021 |
| 185 | Glyco-NPs | Glycans coated nanoparticles as a biocompatible shield to increase nanoparticles colloidal stability and modulate their immunological response. | 2020 |
| 186 | SupraRNA | A Comprehensive Supramolecular Approach for an RNA vaccine for Influenza A (H1N1) | 2020 |